Skip to main content
. 2014 Jul;6(4):180–194. doi: 10.1177/1758834014529175

Table 3.

Results with IHP for patients with colorectal cancer liver metastases treated with IHP.

Treatment regimen Numberof evaluable patients CR PR Median PFS months
Overall 114 2 67 7.0
59%
IHP–no HAI 58 0 33 5.8
57%
IHP–HAI 46 2 30 13.0
65%
IHP (TNF alone) 10 0 4 3.0

IHP, isolated hepatic perfusion; PR, partial response; CR, complete response; TNF, tumor necrosis factor; HAI, hepatic artery infusion.